Aim To evaluate the Limberg or rhomboid fl ap done during the past 2 years with regard to applicability, reliability and complications.Methods All Limberg fl aps done were reviewed by inspecting case records and directly following up patients. The indications, suitability, post-operative course and complications were noted.Results Eleven Limberg fl aps were done during this period. Seven patients underwent the procedure for cutaneous malignancies. Rest for various benign lesions. All the fl aps survived. One patient developed a hematoma under the fl ap. A signifi cant cosmetic defect was noted in two patients.
ConclusionThe Limberg fl ap is a safe and reliable fl ap for the coverage of various cutaneous defects if properly planned.
Aim:To evaluate the fan flaps done during the past two years with regard to applicability, reliability, functional perspective and complications.Materials and Methods:All the fan flaps done were reviewed by inspecting case records and directly following up the patients (at periodic intervals). The indications, applicability to defect size, postoperative aesthetic and functional results and drawbacks were noted.Results: Eight fan flaps were done during this period. All were done for squamous cell carcinoma affecting lower lip. All the flaps survived. Two early cases of Gilles fan flap developed significant microstomia. Later flaps with neurovascular preservation maintained sensations with good commissural competence. Nakajima fan flaps gave good overall results.Conclusions: The fan flaps, especially the Nakajima modification with neurovascular preservation are safe and reliable flaps for lip reconstruction in terms of form and function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.